Skip to content

Different Local Anesthetic Volumes for TPVB in Post-thoracotomy Analgesia

Comparison of Different Local Anesthetic Volumes of Thoracic Paravertebral Block Application in Post-thoracotomy Analgesia

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05700357
Enrollment
75
Registered
2023-01-26
Start date
2022-12-28
Completion date
2024-12-28
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pain, Local Anesthetic, Postoperative Analgesia, Thoracic Paravertebral Block, Thoracotomy

Brief summary

Thoracotomy is one of the most painful operations known. Therefore, it causes severe acute pain. If pain is not controlled, it increases the frequency of postoperative pulmonary complications and postoperative morbidity. It can even cause chronic pain in the future. Thoracic epidural analgesia (TEA) is the gold standard method in the treatment of pain after thoracotomy. Thoracic paravertebral block (TPVB) is known as the most effective method after TEA. The fact that TPVB has fewer side effects than TEA increases the use of TPVB. There is no consensus on the dose of analgesia in studies. In the literature, volumes between 20 ml and 30 ml are frequently used for TPVB in recent years. This study, it was aimed to compare the efficacy of 20 ml, 25 ml, and 30 ml volumes of TPVB with local anesthetic at the same concentration (0.25% bupivacaine) on postoperative analgesia in patients undergoing thoracotomy.

Interventions

PROCEDURETPVB with 20 ml

The thoracic paravertebral block will be applied to the patients with 20 ml of 0.25% bupivacaine under real-time ultrasound guidance.

PROCEDURETPVB with 25 ml

The thoracic paravertebral block will be applied to the patients with 25 ml of 0.25% bupivacaine under real-time ultrasound guidance.

PROCEDURETPVB with 30 ml

The thoracic paravertebral block will be applied to the patients with 30 ml of 0.25% bupivacaine under real-time ultrasound guidance.

Sponsors

Ankara City Hospital Bilkent
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 18 to 80 years old * American Society of Anesthesiologists (ASA) physical status I-II-III * BMI 18 to 40 kg/m2 * Elective thoracotomy surgery

Exclusion criteria

* Patient refusing the procedure * Emergency surgery * History of chronic opioid or analgesic used

Design outcomes

Primary

MeasureTime frameDescription
Pain Scores1st hour after surgeryPain will be assessed at the first-hour rest and while coughing using the visual analog scale on a scale from 0 (no pain) to 10 (worst pain).

Secondary

MeasureTime frameDescription
Morphine Consumption24 hours after surgeryMorphine consumption for 24 hours will be recorded

Countries

Turkey (Türkiye)

Contacts

Primary ContactEmine N ZENGİN
nilbavullu@yahoo.com+905063370548

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026